Eric Klasen

CEO, Obelis GmbH, Switzerland

Consultant in Life Sciences and expert in Regulatory Affairs, QA, and Quality Management Systems

Prior to retirement from Medtronic International Trading, Switzerland, where he served from July 2004 – May 2019 as Vice President EMEA Regulatory Affairs & Quality, and as Founder and President of Medtronic BioPharma EU and CH, he held the following positions:

  • Head of Global Drug Regulatory Affairs at Novartis Consumer Health, Nyon-Switzerland (currently GSK Consumer Healthcare)
  • Director Regulatory Compliance, Quality Assurance and Quality Control at Chiron Vaccines (currently GSK Vaccines), Siena- Italy
  • Director of QA/QC at Serono Biotech, Aubonne-Switzerland (currently Merck–Serono)
  • Director Operations Technical Support at IFS-Serono, Rome-Italy
  • Director R&D and QC at Serono Diagnostics, Rome-Italy
  • Head of the Immunochemistry Department at the TNO Medical Biological Laboratory, Rijswijk-Netherlands
  • Researcher at the Dept of Human Genetics of the University of Leiden, Netherlands

Current positions:

  • Board of Directors member of EFGCP, Belgium
  • Board f Directors member of SimpliNext, Switzerland,
  • Advisory Board member of REA Diagnostics,
  • Supervisory Board member of Diabeter, a group of Diabetes clinics in the NL
  • Chair of the Supervisory Board of NOK, a group of Obesity Clinics in the NL.


  • (1977) in Biochemistry & Genetics, University of Leiden, the Netherlands
  • (1975) in Biochemistry, University of Leiden, the Netherlands